These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 8937431)

  • 1. Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.
    Snead OC
    Biochem Pharmacol; 1996 Oct; 52(8):1235-43. PubMed ID: 8937431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB.
    Banerjee PK; Snead OC
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1534-43. PubMed ID: 7791129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
    Mathivet P; Bernasconi R; De Barry J; Marescaux C; Bittiger H
    Eur J Pharmacol; 1997 Feb; 321(1):67-75. PubMed ID: 9083788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic GABAB-and gamma-hydroxybutyric acid-mediated mechanisms in generalized absence seizures.
    Snead OC
    Neuropharmacology; 1996 Mar; 35(3):359-67. PubMed ID: 8783211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
    J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
    Bernasconi R; Lauber J; Marescaux C; Vergnes M; Martin P; Rubio V; Leonhardt T; Reymann N; Bittiger H
    J Neural Transm Suppl; 1992; 35():155-77. PubMed ID: 1324978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures.
    Snead OC
    Brain Res; 1994 Oct; 659(1-2):147-56. PubMed ID: 7820656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiabsence seizure activity of specific GABAB and gamma-Hydroxybutyric acid receptor antagonists.
    Snead OC
    Pharmacol Biochem Behav; 1996 Jan; 53(1):73-9. PubMed ID: 8848463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor.
    Snead OC
    J Neurochem; 2000 Nov; 75(5):1986-96. PubMed ID: 11032888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors.
    Emri Z; Antal K; Crunelli V
    Neurosci Lett; 1996 Sep; 216(2):121-4. PubMed ID: 8904798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat.
    Hu RQ; Banerjee PK; Snead OC
    Neuropharmacology; 2000 Jan; 39(3):427-39. PubMed ID: 10698009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
    Koek W; Carter LP; Wu H; Coop A; France CP
    Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors.
    Carter LP; Wu H; Chen W; Cruz CM; Lamb RJ; Koek W; Coop A; France CP
    J Pharmacol Exp Ther; 2004 Jan; 308(1):182-8. PubMed ID: 14569056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor.
    Fassio A; Bonanno G; Cavazzani P; Raiteri M
    Eur J Pharmacol; 1994 Oct; 263(3):311-4. PubMed ID: 7843269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
    Gemignani A; Paudice P; Bonanno G; Raiteri M
    Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.
    Koek W; Mercer SL; Coop A
    Psychopharmacology (Berl); 2007 Jun; 192(3):407-14. PubMed ID: 17277933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
    Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
    J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2-hydroxy-saclofen, an antagonist of GABAB action, upon the binding of baclofen and other receptor ligands in rat cerebrum.
    al-Dahan MI; Tehrani MH; Thalmann RH
    Brain Res; 1990 Sep; 526(2):308-12. PubMed ID: 2175242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors.
    Lingenhoehl K; Brom R; Heid J; Beck P; Froestl W; Kaupmann K; Bettler B; Mosbacher J
    Neuropharmacology; 1999 Nov; 38(11):1667-73. PubMed ID: 10587082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.